Financial reports
10-K
2023 FY
Annual report
29 Mar 24
10-Q
2023 Q3
Quarterly report
13 Nov 23
10-Q
2023 Q2
Quarterly report
11 Aug 23
10-Q
2023 Q1
Quarterly report
10 May 23
10-K/A
2022 FY
Annual report (amended)
28 Apr 23
10-K
2022 FY
Annual report
17 Mar 23
10-Q
2022 Q3
Quarterly report
14 Nov 22
10-Q
2022 Q2
Quarterly report
15 Aug 22
10-Q
2022 Q1
Quarterly report
16 May 22
10-K
2021 FY
Annual report
30 Mar 22
Current reports
8-K
Other Events
5 Apr 24
8-K
Results of Operations and Financial Condition
29 Mar 24
8-K
Entry into a Material Definitive Agreement
18 Mar 24
8-K
Departure of Directors or Certain Officers
2 Feb 24
8-K
Other Events
17 Jan 24
8-K
Other Events
16 Jan 24
8-K
Nature Medicine Publishes Updated Preliminary Phase 1 Data From Elicio Therapeutic’s AMPLIFY-201 Phase 1 Solid Tumor Study of ELI-002
9 Jan 24
8-K
Entry into a Material Definitive Agreement
22 Dec 23
8-K
Results of Operations and Financial Condition
9 Nov 23
8-K
Other Events
3 Nov 23
Registration and prospectus
S-8
Registration of securities for employees
29 Mar 24
S-3
Shelf registration
29 Mar 24
D
$6.00 mm in options / securities to be acquired, sold $6.00 mm, 1 investor
28 Mar 24
D
$7.05 mm in equity, sold $7.05 mm, 1 investor
5 Jan 24
S-8
Registration of securities for employees
21 Aug 23
425
Business combination disclosure
30 May 23
425
Business combination disclosure
23 May 23
424B3
Prospectus supplement
28 Apr 23
Other
EFFECT
Notice of effectiveness
1 May 23
SEC STAFF
SEC staff action: Order
28 Apr 23
CORRESP
Correspondence with SEC
26 Apr 23
CORRESP
Correspondence with SEC
21 Apr 23
UPLOAD
Letter from SEC
20 Apr 23
CORRESP
Correspondence with SEC
13 Apr 23
UPLOAD
Letter from SEC
7 Apr 23
SEC STAFF
SEC staff action: Order
6 Apr 23
CORRESP
Correspondence with SEC
29 Mar 23
UPLOAD
Letter from SEC
10 Mar 23
Ownership
SC 13D/A
Clal Biotechnology Industries Ltd.
10 Apr 24
SC 13D/A
Clal Biotechnology Industries Ltd.
20 Mar 24
SC 13D/A
GKCC, LLC
20 Mar 24
4
Yekaterina Chudnovsky
20 Mar 24
4
Brian Piekos
5 Feb 24
4
Robert Connelly
5 Feb 24
4
Christopher Haqq
5 Feb 24
4
Peter DeMuth
5 Feb 24
4
Allen Nissenson
29 Dec 23
4
Yekaterina Chudnovsky
29 Dec 23